Lupin's Brivaracetam Oral Solution approved by US FDA
Johnson & Johnson submits sBLA to FDA for first-ever treatment for wAIHA
AlzeCure's ACD440 granted EU orphan drug status for erythromelalgia
Armata Pharmaceuticals' AP-SA02 receives QIDP designation from US FDA
Immedica Pharma's Loargys (pegzilarginase-nbln) receives accelerated US FDA approval
Gossamer Bio reports topline Phase 3 PROSERA results for seralutinib in PAH
Organon licenses MIUDELLA IUD from Sebela Pharmaceuticals
Gilead to acquire Arcellx to gain full control of anito-cel
Novo Nordisk's CagriSema achieves 23% weight loss but misses primary endpoint in REDEFINE 4 trial
AbbVie's VENCLEXTA (venetoclax) and acalabrutinib combination receives US FDA approval to treat CLL
Vanda Pharmaceuticals' BYSANTI (milsaperidone) tablets receive US FDA approval
FDA approves Genentech oral Venclexta plus AstraZeneca's Calquence combination for first-line CLL
EMA validates Enhertu application for post-neoadjuvant HER2-positive early breast cancer
Merck reports positive Phase 3 data for Enflonsia in high-risk children across two RSV seasons